Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
Department of Visceral-, Thoracic- and Vascular Surgery, University Hospital Carl Gustav Carus, Technical University Dresden, Germany
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cancers 2010, 2(2), 1107-1124; https://doi.org/10.3390/cancers2021107
Received: 24 March 2010
/
Revised: 21 May 2010
/
Accepted: 24 May 2010
/
Published: 2 June 2010
(This article belongs to the Special Issue Pancreatic Cancer)
The low prevalence of pancreatic cancer remains an obstacle to the development of effective screening tools in an asymptomatic population. However, development of effective serologic markers still offers the potential for improvement of diagnostic capabilities, especially for subpopulations of patients with high risk for pancreatic cancer. The accurate identification of patients with pancreatic cancer and the exclusion of disease in those with benign disorders remain important goals. While clinical experience largely dismissed many candidate markers as useful markers of pancreatic cancer, CA19-9 continues to show promise. The present review highlights the development and the properties of different tumor markers in pancreatic cancer and their impact on the diagnostic and treatment of this aggressive disease.
View Full-Text
Keywords:
pancreatic cancer; serum tumor markers
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License.
MDPI and ACS Style
Rückert, F.; Pilarsky, C.; Grützmann, R. Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries. Cancers 2010, 2, 1107-1124. https://doi.org/10.3390/cancers2021107
AMA Style
Rückert F, Pilarsky C, Grützmann R. Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries. Cancers. 2010; 2(2):1107-1124. https://doi.org/10.3390/cancers2021107
Chicago/Turabian StyleRückert, Felix, Christian Pilarsky, and Robert Grützmann. 2010. "Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries" Cancers 2, no. 2: 1107-1124. https://doi.org/10.3390/cancers2021107
Find Other Styles
